Marquette Asset Management LLC acquired a new stake in Seer, Inc. (NASDAQ:SEER – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 49,264 shares of the company’s stock, valued at approximately $96,000. A number of other hedge funds and other institutional investors also […]
Seer, Inc. (NASDAQ:SEER – Get Free Report) insider Elona Esq. Kogan sold 8,182 shares of the business’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $1.70, for a total value of $13,909.40. Following the transaction, the insider now owns 162,673 shares of the company’s stock, valued […]
Seer (NASDAQ:SEER – Get Free Report) and Nautilus Biotechnology (NASDAQ:NAUT – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation. Earnings and Valuation This table compares Seer and […]
Seer (NASDAQ:SEER – Get Free Report) and Singular Genomics Systems (NASDAQ:OMIC – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Profitability This table compares Seer and Singular […]
Seer (NASDAQ:SEER – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership and earnings. Analyst Recommendations This is a summary of recent recommendations and […]